Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
WASHINGTON – American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc. (hereinafter together "Pfizer") have agreed to pay $2.3 billion, the largest health care fraud settlement in the history of the Department of Justice, to resolve criminal and civil liability arising from the illegal promotion of certain pharmaceutical products, the Justice Department The Case of Neurontin: Skewed Research in the Service of Selling. December 2009. Annette B. Ramírez de Arellano, DrPH. When pharmaceuticals are intent on proving that one of their products is safe and effective, they may engage in practices that are professionally suspect and morally unethical. The recent news on Neurontin is a case in point. Warner-Lambert promoted Neurontin even when scientific studies had shown it was not effective. For example, the company promoted Neurontin as effective for use as the sole drug (monotherapy) for epileptic seizures, even after solo use had been specifically rejected by the FDA. By Lawrence Hurley WASHINGTON (Reuters) - The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc over the marketing of the epilepsy drug Neurontin. In 2010 AHRP reports on Pfizer's criminal fraud in marketing Neurontin for unapproved uses and paying physicians to prescribe it. The article also exposes the conflicts of interest and corrupt practices in psychiatry and the drug industry. The manufacturers of the drug Neurontin reached a $325 million class action lawsuit settlement Wednesday over allegations they fraudulently marketed the prescription drug, which is used to treat seizures, restless leg syndrome, and pain caused by shingles. On January 15 of this year, US federal prosecutors in Boston filed a complaint against Johnson & Johnson (J&J) and related companies, alleging violations of the federal False Claims Act and related legislation (Associated Press 2010). 1 Allegedly, from 1999 through 2004, J&J made payments to Omnicare to induce increased prescribing of Risperdal to patients in nursing homes. Pfizer Inc <PFE.N> violated federal racketeering law by improperly promoting the epilepsy drug Neurontin, a Boston jury found on Thursday, and the world's largest drugmaker was ordered to pay $47 And police in Ohio have reported a dramatic rise in the abuse of gabapentin, better known by brand names like Neurontin, Gralise or Horizant. There have already been reports of 300 milligram Pfizer, the world's largest drug maker, pleaded guilty on 13 May to numerous civil and criminal charges for illegally promoting the off-label use of gabapentin (Neurontin). It has agreed to pay a $240m (£136m; €200m) criminal fine and $152m to state and federal healthcare programmes. Federal prosecutors on Thursday announced that Pfizer has agreed to plead guilty to criminal wrongdoing and pay a settlement of $430 million in a whistleblower lawsuit alleging that the Parke-Davis unit of Pfizer subsidiary Warner-Lambert illegally encouraged physicians to prescribe the epilepsy drug Neurontin to treat conditions other than those approved by FDA, USA Today reports. A federal appeals court has upheld a $142 million jury verdict in a case involving Pfizer’s epilepsy drug Neurontin, and opened the door for potentially even more lawsuits. The U.S. Supreme Court on Monday left intact a $142 million jury verdict against Pfizer Inc over the marketing of the epilepsy drug Neurontin. Pfizer Inc has agreed to pay $325 million to resolve claims it defrauded insurers and other healthcare benefit providers by marketing Neurontin for unapproved uses, its second settlement over the — -- In the largest health care fraud settlement in history, pharmaceutical giant Pfizer must pay $2.3 billion to resolve criminal and civil allegations that the company illegally promoted Dr. Sidney Wolfe, co-founder of Public Citizen Health Research Group, called it “preposterous in the context of the Neurontin scandal,” a reference to a $430 million legal settlement Pfizer In 2004, Pfizer agreed to pay $430 million in a DOJ settlement and pleaded guilty to two violations of the Food, Drug and Cosmetic Act for marketing the drug Neurontin, also known as Recently, lawsuits alleging damages from illegal marketing of another old drug, gabapentin (Neurontin), have yielded remarkable discoveries about the structure and function of pharmaceutical The Neurontin scandal primarily revolves around the illegal and unethical marketing practices of Pfizer (formerly Warner-Lambert) regarding the drug gabapentin, sold under the brand name Neurontin. The whistleblower lawsuit alleged that the company's publicity plan for Neurontin included paying doctors to put their names on ghostwritten articles about Neurontin and to fly them to lavish
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |